Playlist

French pianist Christine Fonlupt performs successfully in Ashgabat

10 Apr. 14:40

Source

A major cultural event took place in Ashgabat as renowned French pianist Christine Fonlupt performed in the capital for the first time. The concert was held together with the State Symphony Orchestra of Turkmenistan and attracted strong interest from classical music lovers.

 

The musical evening took place on April 10 at the National Music and Drama Theatre named after Magtymguly. From the very beginning, the atmosphere in the hall reflected high anticipation, with a full audience eagerly awaiting the start of the performance.

 

The program featured masterpieces of French classical music. Works by Claude Debussy, Georges Bizet, Maurice Ravel, Cécile Chaminade, and Mel Bonis were performed, bringing the richness of the French musical tradition to life through piano and orchestral interpretation.

 

Christine Fonlupt’s performance stood out for its emotional depth and refined technique. She is regarded as one of the prominent figures of contemporary French piano artistry, and her interpretation created a deeply expressive and immersive atmosphere throughout the evening.

 

The general sponsor of the concert was LeTravel, an international travel and visa service company specializing in trip organization, visa support, and full-stage traveler assistance, as well as supporting cultural and international projects.

 

At the end of the concert, the audience responded with long and warm applause, expressing appreciation for the high artistic level of the performance. The event became an important milestone in Ashgabat’s cultural life and highlighted growing international musical cooperation.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌

Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds

Today in 02:02

Source

Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.

Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.

‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌